SINTX TECHNOLOGIES INC (SINT) Stock News

USA - NASDAQ:SINT - US8293927039 - Common Stock

3.27 USD

-0.12 (-3.54%)

Last: 11/7/2025, 8:17:45 PM

3.45 USD

+0.18 (+5.5%)

After Hours: 11/7/2025, 8:17:45 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

SINT Latest News, Press Relases and Analysis

All

Press Releases

3 days ago - By: Benzinga - Mentions: CDXS WORX IRD PPBT ...

12 Health Care Stocks Moving In Friday's After-Market Session

3 days ago - By: Zacks Investment Research - Mentions: TNDM

Tandem Diabetes Care, Inc. (TNDM) Reports Q3 Loss, Tops Revenue Estimates

6 days ago - By: Zacks Investment Research - Mentions: STIM

Neuronetics (STIM) Reports Q3 Loss, Misses Revenue Estimates

7 days ago - By: SINTX Technologies, Inc.

SINTX Technologies Announces Launch of OsseoSculpt™ an Advanced Biologic for Use with SINAPTIC® Foot & Ankle Osteotomy Wedge System

18 days ago - By: Zacks Investment Research - Mentions: ITGR

Integer (ITGR) Beats Q3 Earnings and Revenue Estimates

21 days ago - By: SiNtx Technologies, Inc.

SINTX Technologies obtiene aprobación de la FDA para el sistema de implantes SINAPTIC® para pie y tobillo

3 months ago - By: Benzinga

Peering Into SINTX Technologies's Recent Short Interest

21 days ago - By: SiNtx Technologies, Inc.

SINTX Technologies Recebe Autorização da FDA para Sistema de Implantes de Pé e Tornozelo SINAPTIC®

21 days ago - By: SiNtx Technologies, Inc.

SINTX Technologies Menerima Kelulusan FDA untuk SINAPTIC® Foot & Ankle Implant System

21 days ago - By: SiNtx Technologies, Inc.

SINTX 테크놀로지스, SINAPTIC® 발·발목 임플란트 시스템에 대해 FDA 승인 획득

21 days ago - By: SiNtx Technologies, Inc.

シントクス・テクノロジーズ (SINTX Technologies)、SINAPTIC®足・足首用インプラントシステムでFDA認可を取得

21 days ago - By: SiNtx Technologies, Inc.

SINTX Technologies Mendapatkan Persetujuan dari FDA untuk Sistem Implan Kaki dan Pergelangan Kaki SINAPTIC®

21 days ago - By: SiNtx Technologies, Inc.

SINTX Technologies erhält FDA-Zulassung für SINAPTIC® Fuß- und Sprunggelenk-Implantatsystem

21 days ago - By: SiNtx Technologies, Inc.

La FDA autorise le système d’implant de pied et de cheville SINAPTIC® de SINTX Technologies

21 days ago - By: SiNtx Technologies, Inc.

SINTX Technologies ได้รับการรับรองจาก FDA สำหรับระบบปลูกถ่ายเท้าและข้อเท้า SINAPTIC®

21 days ago - By: SiNtx Technologies, Inc.

SINTX Technologies 的 SINAPTIC® 足踝植入系统获得 FDA 上市许可

21 days ago - By: SINTX Technologies, Inc.

SINTX Technologies Receives FDA Clearance for SINAPTIC® Foot & Ankle Implant System

21 days ago - By: SINTX Technologies, Inc.

SINTX Technologies Receives FDA Clearance for SINAPTIC® Foot & Ankle Implant System

25 days ago - By: SiNtx Technologies, Inc.

ACTUALIZACIÓN: SINTX fortalece su portafolio de prevención de infecciones con una patente estadounidense recientemente autorizada que cubre un mercado antipatógeno direccionable de 30 mil millones de dólares

25 days ago - By: SiNtx Technologies, Inc.

ATUALIZAÇÃO: SINTX Fortalece Portfólio de Prevenção de Infecções com a Recente Patente nos EUA que Abrange um Mercado de US $30 bilhões Endereçável Antipatogênico

25 days ago - By: SiNtx Technologies, Inc.

KEMAS KINI: SINTX Perkukuh Portfolio Pencegahan Jangkitan dengan Paten Baharu yang Diluluskan di AS, Meliputi Pasaran Antipatogenik Bernilai AS$30 Bilion

25 days ago - By: SiNtx Technologies, Inc.

更新：シントクス (SINTX)、3,000億米ドル (約44兆3,496億3,478万円) 規模の抗病原性アドレス可能市場を対象とする新たな米国特許の許可取得により感染防止ポートフォリオを強化

25 days ago - By: SiNtx Technologies, Inc.

KABAR TERBARU: SINTX Memperkuat Portofolio Pencegahan Infeksi dengan Paten A.S. yang Baru Disetujui yang Mencakup Pasar Antipatogenik yang Dapat Dijangkau senilai $30 Miliar

25 days ago - By: SiNtx Technologies, Inc.

עדכון: SINTX מחזקת את תיק הפיתוחים למניעת זיהומים עם פטנט אמריקני חדש המכסה שוק אנטי-פתוגני בשווי 30 מיליארד דולר

25 days ago - By: SiNtx Technologies, Inc.

UPDATE: SINTX stärkt sein Portfolio zur Infektionsprävention mit einem neu zugelassenen US-Patent, das einen adressierbaren Markt für Antipathogene im Wert von 30 Milliarden US-Dollar abdeckt

25 days ago - By: SiNtx Technologies, Inc.

MISE À JOUR : SINTX renforce son portefeuille de produits de prévention des infections grâce à un nouveau brevet américain couvrant un marché antipathogène potentiel de 30 milliards de dollars

25 days ago - By: SiNtx Technologies, Inc.

업데이트: SINTX, 신규 미국 특허 승인으로 300억 달러 규모 항병원성 시장 공략 강화

25 days ago - By: SINTX Technologies, Inc.

UPDATE: SINTX Strengthens Infection-Prevention Portfolio with Newly Allowed U.S. Patent Covering $30 Billion Antipathogenic Addressable Market

25 days ago - By: SINTX Technologies, Inc.

UPDATE: SINTX Strengthens Infection-Prevention Portfolio with Newly Allowed U.S. Patent Covering $30 Billion Antipathogenic Addressable Market

a month ago - By: SINTX Technologies, Inc.

SINTX Technologies Strengthens IP Portfolio with New U.S. Patent Notice of Allowance Covering Antipathogenic Fabrics

2 months ago - By: SINTX Technologies, Inc.

SINTX Technologies Announces Successful Exercise of Warrants for $3.8 Million Gross Proceeds

2 months ago - By: SINTX Technologies, Inc.

SINTX Technologies Receives USPTO Notice of Allowance for Silicon Nitride Antipathogenic Platform Patent

2 months ago - By: SINTX Technologies, Inc.

SINTX Technologies Publishes Landmark Study Demonstrating Broad-Spectrum Antiviral Activity of Silicon Nitride

3 months ago - By: SINTX Technologies, Inc.

SINTX Technologies Issues Business Update Following Strategic Realignment, Leadership Expansion, and SiNAPTIC Acquisition